ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially

Journal of Biology

Volumn 5, Issue , 2006, Pages

  Vantaggiato, Chiara ^a,b   Formentini, Ivan ^a   Bondanza, Attilio ^a   Bonini, Chiara ^a   Naldini, Luigi ^a   Brambilla, Riccardo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CATALYSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE TARGETING; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; ENZYME ACTIVATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NUDE MOUSE;

MUS MUSCULUS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; GENE SILENCING; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUTATION; PROTEIN BINDING; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33845904217     PISSN: 14785854     EISSN: 14754924     Source Type: Journal    
DOI: 10.1186/jbiol38     Document Type: Article

References (59)

1. RAS oncogenes: the first 30 years. M Malumbres M Barbacid, Nat Rev Cancer 2003 3 459 465 10.1038/nrc1097 12778136
2. RAS and RHO GTPases in G1-phase cell-cycle regulation. ML Coleman CJ Marshall MF Olson, Nat Rev Mol Cell Biol 2004 5 355 366 10.1038/nrm1365 15122349
3. Is the Ras-MAPK signaling pathway necessary for long-term memory formation? PC Orban PF Chapman R Brambilla, Trends Neurosci 1999 22 38 44 10.1016/S0166-2236(98)01306-X 10088998
4. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. G Pearson F Robinson T Beers Gibson BE Xu M Karandikar K Berman MH Cobb, Endocr Rev 2001 22 153 183 10.1210/er.22.2.153 11294822
5. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. J Pouyssegur P Lenormand, Eur J Biochem 2003 270 3291 3299 10.1046/j.1432-1033. 2003.03707.x 12899687
6. Mammalian MAP kinase signalling cascades. L Chang M Karin, Nature 2001 410 37 40 10.1038/35065000 11242034
7. The ERK cascade as a prototype of MAPK signaling pathways. H Rubinfeld R Seger, Methods Mol Biol 2004 250 1 28 14755077
8. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. S Yoon R Seger, Growth Factors 2006 24 21 44 16393692
9. ras oncogenes in human cancer: a review. JL Bos, Cancer Res 1989 49 4682 4689 2547513
10. Mutations of the BRAF gene in human cancer. H Davies GR Bignell C Cox P Stephens S Edkins S Clegg J Teague H Woffendin MJ Garnett W Bottomley, Nature 2002 417 949 954 10.1038/nature00766 12068308
11. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. R Hoshino Y Chatani T Yamori T Tsuruo H Oka O Yoshida Y Shimada S Ari-i H Wada J Fujimoto M Kohno, Oncogene 1999 18 813 822 10.1038/sj.onc.1202367 9989833
12. The mitogen-activated protein kinase signaling module as a therapeutic target in hematologic malignancies. M Milella SM Kornblau M Andreeff, Rev Clin Exp Hematol 2003 7 160 190 14763161
13. NF1 tumor suppressor gene function: narrowing the GAP. K Cichowski T Jacks, Cell 2001 104 593 604 10.1016/S0092-8674(01)00245-8 11239415
14. Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. M Henkemeyer DJ Rossi DP Holmyard MC Puri G Mbamalu K Harpal TS Shih T Jacks T Pawson, Nature 1995 377 695 701 10.1038/377695a0 7477259
15. Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development. DZ Wang VE Hammond HE Abud I Bertoncello JW McAvoy DD Bowtell, Genes Dev 1997 11 309 320 9030684
16. A role for the Ras signalling pathway in synaptic transmission and long-term memory. R Brambilla N Gnesutta L Minichiello G White AJ Roylance CE Herron M Ramsey DP Wolfer V Cestari C Rossi-Arnaud, Nature 1997 390 281 286 10.1038/36849 9384379
17. The p66shc adaptor protein controls oxidative stress response and life span in mammals. E Migliaccio M Giorgio S Mele G Pelicci P Reboldi PP Pandolfi L Lanfrancone PG Pelicci, Nature 1999 402 309 313 10.1038/46311 10580504
18. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. AM Cheng TM Saxton R Sakai S Kulkarni G Mbamalu W Vogel CG Tortorice RD Cardiff JC Cross WJ Muller T Pawson, Cell 1998 95 793 803 10.1016/S0092-8674(00)81702-X 9865697
19. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. S Giroux M Tremblay D Bernard JF Cardin-Girard S Aubry L Larouche S Rousseau J Huot J Landry L Jeannotte J Charron, Curr Biol 1999 9 369 372 10.1016/S0960-9822(99)80164-X 10209122
20. Essential role for oncogenic Ras in tumour maintenance. L Chin A Tam J Pomerantz M Wong J Holash N Bardeesy Q Shen R O'Hagan J Pantginis H Zhou, Nature 1999 400 468 472 10.1038/22788 10440378
21. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. L Johnson K Mercer D Greenbaum RT Bronson D Crowley DA Tuveson T Jacks, Nature 2001 410 1111 1116 10.1038/35074129 11323676
22. Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development. A Fernandez-Medarde LM Esteban A Nunez A Porteros L Tessarollo E Santos, Mol Cell Biol 2002 22 2498 2504 11909944 10.1128/MCB.22.8.2498-2504. 2002
23. Mek2 is dispensable for mouse growth and development. LF Belanger S Roy M Tremblay B Brott AM Steff W Mourad P Hugo R Erikson J Charron, Mol Cell Biol 2003 23 4778 4787 12832465 10.1128/MCB.23.14.4778-4787.2003
24. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. C Guerra N Mijimolle A Dhawahir P Dubus M Barradas M Serrano V Campuzano M Barbacid, Cancer Cell 2003 4 111 120 10.1016/S1535-6108(03)00191-0 12957286
25. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. PT Wan MJ Garnett SM Roe S Lee D Niculescu-Duvaz VM Good CM Jones CJ Marshall CJ Springer D Barford, Cell 2004 116 855 867 10.1016/S0092-8674(04)00215-6 15035987
26. Molecular psychology: roles for the ERK MAP kinase cascade in memory. JP Adams JD Sweatt, Annu Rev Pharmacol Toxicol 2002 42 135 163 10.1146/annurev. pharmtox.42.082701.145401 11807168
27. Study of MAPK signaling using knockout mice. G Pages J Pouyssegur, Methods Mol Biol 2004 250 155 166 14755087
28. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. G Pagès S Guerin D Grall F Bonino A Smith F Anjuere P Auberger J Pouysségur, Science 1999 286 1374 1377 10.1126/science.286.5443.1374 10558995
29. The role of Erk1 and Erk2 in multiple stages of T cell development. AM Fischer CD Katayama G Pages J Pouyssegur SM Hedrick, Immunity 2005 23 431 443 10.1016/j.immuni.2005.08.013 16226508
30. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. MK Saba-El-Leil FD Vella B Vernay L Voisin L Chen N Labrecque SL Ang S Meloche, EMBO Rep 2003 4 964 968 14502223 10.1038/sj.embor.embor939
31. Essential role for ERK2 mitogen-activated protein kinase in placental development. N Hatano Y Mori M Oh-hora A Kosugi T Fujikawa N Nakai H Niwa J Miyazaki T Hamaoka M Ogata, Genes Cells 2003 8 847 856 10.1046/j.1365-2443.2003. 00680.x 14622137
32. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Y Yao W Li J Wu UA Germann MS Su K Kuida DM Boucher, Proc Natl Acad Sci USA 2003 100 12759 12764 14566055 10.1073/pnas.2134254100
33. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. C Mazzucchelli C Vantaggiato A Ciamei S Fasano P Pakhotin W Krezel H Welzl DP Wolfer G Pages O Valverde, Neuron 2002 34 807 820 10.1016/S0896-6273(02)00716-X 12062026
34. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. A Fire S Xu MK Montgomery SA Kostas SE Driver CC Mello, Nature 1998 391 806 811 10.1038/35888 9486653
35. RNA interference: listening to the sound of silence. PD Zamore, Nat Struct Biol 2001 8 746 750 10.1038/nsb0901-746 11524674
36. RNA interference. GJ Hannon, Nature 2002 418 244 251 10.1038/418244a 12110901
37. A system for stable expression of short interfering RNAs in mammalian cells. TR Brummelkamp R Bernards R Agami, Science 2002 296 550 553 10.1126/science.1068999 11910072
38. Ancient pathways programmed by small RNAs. PD Zamore, Science 2002 296 1265 1269 10.1126/science.1072457 12016303
39. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. DA Rubinson CP Dillon AV Kwiatkowski C Sievers L Yang J Kopinja DL Rooney MM Ihrig MT McManus FB Gertler, Nat Genet 2003 33 401 406 10.1038/ng1117 12590264
40. RNA interference: the new somatic cell genetics? PJ Paddison GJ Hannon, Cancer Cell 2002 2 17 23 10.1016/S1535-6108(02)00092-2 12150821
41. A synthetic inhibitor of the mitogen-activated protein kinase cascade. DT Dudley L Pang SJ Decker AJ Bridges AR Saltiel, Proc Natl Acad Sci USA 1995 92 7686 7689 7644477 10.1073/pnas.92.17.7686
42. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. MF Favata KY Horiuchi EJ Manos AJ Daulerio DA Stradley WS Feeser DE Van Dyk WJ Pitts RA Earl F Hobbs, J Biol Chem 1998 273 18623 18632 10.1074/jbc.273.29.18623 9660836
43. Targeting the mitogen-activated protein kinase cascade to treat cancer. JS Sebolt-Leopold R Herrera, Nat Rev Cancer 2004 4 937 947 10.1038/nrc1503 15573115
44. Proliferation of human malignant astrocytomas is dependent on Ras activation. A Guha MM Feldkamp N Lau G Boss A Pawson, Oncogene 1997 15 2755 2765 10.1038/sj.onc.1201455 9419966
45. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate. MJ Robinson PC Harkins J Zhang R Baer JW Haycock MH Cobb EJ Goldsmith, Biochemistry 1996 35 5641 5646 10.1021/bi952723e 8639522
46. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Z Zhang Y Wang HG Vikis L Johnson G Liu J Li MW Anderson RC Sills HL Hong TR Devereux, Nat Genet 2001 29 25 33 10.1038/ng721 11528387
47. A ras-related gene with transformation suppressor activity. H Kitayama Y Sugimoto T Matsuzaki Y Ikawa M Noda, Cell 1989 56 77 84 10.1016/0092-8674(89) 90985-9 2642744
48. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. JL Bos, EMBO J 1998 17 6776 6782 9843482 10.1093/emboj/17.23.6776
49. Does Rap1 deserve a bad Rap? PJ Stork, Trends Biochem Sci 2003 28 267 275 10.1016/S0968-0004(03)00087-2 12765839
50. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. W Kolch, Nat Rev Mol Cell Biol 2005 6 827 837 10.1038/nrm1743 16227978
51. Protein-protein interactions in the regulation of the extracellular signal-regulated kinase. D Chuderland R Seger, Mol Biotechnol 2005 29 57 74 10.1385/MB:29:1:57 15668520
52. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. A Levchenko J Bruck PW Sternberg, Proc Natl Acad Sci USA 2000 97 5818 5823 10823939 10.1073/pnas.97.11.5818
53. Cell-signalling dynamics in time and space. BN Kholodenko, Nat Rev Mol Cell Biol 2006 7 165 176 16482094
54. WI siRNA selection program. [http://jura.wi.mit.edu/bioc/siRNAext]
55. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. A Follenzi LE Ailles S Bakovic M Geuna L Naldini, Nat Genet 2000 25 217 222 10.1038/76095 10835641
56. HIV-based vectors. Preparation and use. A Follenzi L Naldini, Methods Mol Med 2002 69 259 274 11987783
57. Transduction of a gene expression cassette using advanced generation lentiviral vectors. M De Palma L Naldini, Methods Enzymol 2002 346 514 529 11883088
58. CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. NS Foulkes E Borrelli P Sassone-Corsi, Cell 1991 64 739 749 10.1016/0092-8674(91)90503-Q 1847666
59. Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases. R Brambilla A Schnapp F Casagranda JP Labrador AD Bergemann JG Flanagan EB Pasquale R Klein, EMBO J 1995 14 3116 3126 7621826